National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 35122-35123 [2019-15461]

Download as PDF 35122 Federal Register / Vol. 84, No. 140 / Monday, July 22, 2019 / Notices The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Initial Review Group Pediatrics Subcommittee. Date: October 18, 2019. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Rita Anand, Ph.D., Scientific Review Officer, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, (301) 496–1487, anandr@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: July 16, 2019. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–15462 Filed 7–19–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jbell on DSK3GLQ082PROD with NOTICES Office of the Secretary; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Task Force on Research Specific to Pregnant Women and Lactating Women. VerDate Sep<11>2014 19:11 Jul 19, 2019 Jkt 247001 Name of Committee: Task Force on Research Specific to Pregnant Women and Lactating Women. Date: August 22, 2019. Time: 10:30 a.m. to 12:45 p.m. Agenda: Thursday, August 22, 2019—Day 1 10:00 a.m.–10:30 a.m. Registration 10:30 a.m.–12:45 p.m. Open Session (11:45 a.m.–12:45 p.m. Public Comment Period) Date: August 23, 2019. Time: 8:00 a.m. to 1:00 p.m. Agenda: Friday, August 23, 2019—Day 2 8:00 a.m.–1:00 p.m. Open Session Place: 6710B Rockledge Drive, Multipurpose Room 1425/1427 (1st Floor), Bethesda, MD 20817. Contact Person: Lisa Kaeser, Executive Secretary Eunice Kennedy Shriver, National Institute of Child Health and Human Development, 31 Center Drive, Room 2A03, MSC 2425 Bethesda, MD 20892, (301) 496– 0536, kaeserl@mail.nih.gov. Public comments are welcome either by filing written comments and/or providing oral comments at the meeting. Oral comments from the public will be scheduled on August 22, 2019, from approximately 11:45 a.m.–12:45 p.m. Any member of the public interested in presenting oral comments on August 22, 2019, should submit a letter of intent, a brief description of the organization represented, and the oral presentation to Ms. Lisa Kaeser (Kaeserl@ mail.nih.gov) by 5:00 p.m. on Thursday, August 15, 2019. Written comments to be included at the meeting should also be sent to Lisa Kaeser by 5:00 p.m. on Thursday, August 15, 2019. The submitted presentations and any written comments will be formatted to be posted on the PRGLAC website for the record. Only one representative of an organization may be allowed to present oral comments. Presentations will be limited to three to five minutes per speaker depending on the number of speakers to be accommodated within the allotted time. Speakers will be assigned a time to speak in the order of the date and time when their request to speak is received. Both printed and electronic copies are requested for the record. Details and additional information about these meetings can be found at the NICHD website for the Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) https:// www.nichd.nih.gov/about/advisory/PRGLAC/ Pages/index.aspx. Registration Link: https://palladian partners.cvent.com/PRGLAC2019. Please note: This meeting will also be available through NIH Videocast. If you are planning on watching the videocast remotely, PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 please select this option on the registration form. Dated: July 16, 2019. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–15460 Filed 7–19–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring SBIR. Date: August 9, 2019. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Ryan G. Morris, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7015, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, 301–594–4721, ryan.morris@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) E:\FR\FM\22JYN1.SGM 22JYN1 Federal Register / Vol. 84, No. 140 / Monday, July 22, 2019 / Notices Dated: July 16, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–15461 Filed 7–19–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service [Docket No. FWS–R8–ES–2019–0064; FXES11140900000 190] Endangered and Threatened Species; Receipt of an Incidental Take Permit Application and Low-Effect Habitat Conservation Plan for the Desert Tortoise; High Desert Power Project, San Bernardino County, California Fish and Wildlife Service, Interior. ACTION: Notice of availability; request for comments. AGENCY: We, the U.S. Fish and Wildlife Service, have received an application for an incidental permit to take federally listed fish or wildlife species. We invite comments on this application, which we will take into consideration before issuing an incidental take permit. DATES: To ensure consideration, please submit your written comments by August 21, 2019. ADDRESSES: Obtaining Documents: The documents this notice announces, as SUMMARY: Applicant, city, state jbell on DSK3GLQ082PROD with NOTICES HDSI, LLC, Chicago, Illinois. Species Mojave desert tortoise (Gopherus agassizii). well as any comments and other materials that we receive, will be available for public inspection online in Docket No. FWS–R8–ES–2019–0064 at https://www.regulations.gov. Submitting Comments: You may submit comments by one of the following methods: • Online: https://www.regulations.gov. Follow the instructions for submitting comments on Docket No. FWS–R8–ES– 2019–0064. • U.S. mail or hand-delivery: Public Comments Processing, Attn: Docket No. FWS–R8–ES–2019–0064; U.S. Fish and Wildlife Service, MS: JAO/1N; 5275 Leesburg Pike, Falls Church, VA 22041– 3803. We request that you send comments by only the methods described above. FOR FURTHER INFORMATION CONTACT: Raymond Bransfield, Fish and Wildlife Biologist, Palm Springs Fish and Wildlife Office, by phone at 805–677– 3398 or via email at ray_bransfield@ fws.gov. If you use a telecommunications device for the deaf, hard-of-hearing, or speech disabled, please call the Federal Relay Service at 800–877–8339. SUPPLEMENTARY INFORMATION: We have received an application for an incidental take permit under the Endangered Species Act of 1973, as amended (ESA; 16 U.S.C. 1531 et seq.). The application addresses the potential for take of a threatened species that is likely to occur incidental to the otherwise lawful Location activity as described in the applicant’s habitat conservation plan. Background Section 9 of the ESA and Federal regulations pursuant to section 4(d) of the ESA prohibit the take of endangered and threatened species, respectively, without special exemption (16 U.S.C. 1538; 50 CFR 17.31). Under section 10(a)(1)(B) of the ESA (16 U.S.C. 1539), we may issue permits to authorize take of listed fish and wildlife species that is incidental to, and not the purpose of, carrying out an otherwise lawful activity. Regulations governing permits for endangered and threatened species are set forth in title 50 of the Code of Federal Regulations at part 17, sections 17.22 and 17.32. The National Environmental Policy Act (NEPA; 42 U.S.C. 4321 et seq.) requires Federal agencies to analyze their proposed actions to determine whether the actions may significantly affect the human environment. In the NEPA analysis, the Federal agency will identify direct, indirect, and cumulative effects, as well as possible mitigation for effects on environmental resources that could occur with implementation of the proposed action and alternatives. The Federal action in this case is the Service’s proposed issuance of an incidental take permit. Permit Application We invite comments on the following application. Type of take (amount of take over term) Project’s actions to minimize and mitigate for take Approximately 10 large desert tortoises at the solar site. Take (capture) to translocate; kill or wound no more than three if they are not detected prior to work. Minimize by translocation of tortoises to superior habitat. Mitigate by acquiring private lands within the boundaries of critical habitat and managing these lands for long-term conservation. Activity Victorville, Construction, operation, mainteCalifornia. nance, and decommissioning of a photovoltaic solar power facility and management of conserved lands. 35123 Our Preliminary Determination Public Availability of Comments Next Steps The Service has made a preliminary determination that issuance of the incidental take permit is not a major Federal action that will significantly affect the quality of the human environment within the meaning of section 102(2)(C) of the National Environmental Policy Act (NEPA; 42 U.S.C. 4321 et seq.). The Service has also made a preliminary determination that it individually or cumulatively will not have more than a negligible effect on the species covered in the habitat conservation plan. Therefore, the permit qualifies for a categorical exclusion under NEPA. All comments and materials we receive in response to this request will be available for public review at https:// www.regulations.gov. Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. We will publish a notice in the Federal Register when we have made a determination with regard to issuance of the incidental take permit. VerDate Sep<11>2014 19:11 Jul 19, 2019 Jkt 247001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Authority We issue this notice pursuant to section 10(c) of the ESA (16 U.S.C. 1531 et seq.) and its implementing regulations (50 CFR 17.22 and 17.32), and the National Environmental Policy Act (42 U.S.C. 4321 et seq.) and its E:\FR\FM\22JYN1.SGM 22JYN1

Agencies

[Federal Register Volume 84, Number 140 (Monday, July 22, 2019)]
[Notices]
[Pages 35122-35123]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15461]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Develop New Open and 
Closed-Loop Automated Technologies for Better Type 1 Diabetes 
Therapy and Monitoring SBIR.
    Date: August 9, 2019.
    Time: 2:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Ryan G. Morris, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7015, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-
594-4721, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)


[[Page 35123]]


    Dated: July 16, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-15461 Filed 7-19-19; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.